BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32785646)

  • 1. Common Susceptibility Loci for Male Breast Cancer.
    Maguire S; Perraki E; Tomczyk K; Jones ME; Fletcher O; Pugh M; Winter T; Thompson K; Cooke R; ; Trainer A; James P; Bojesen S; Flyger H; Nevanlinna H; Mattson J; Friedman E; Laitman Y; Palli D; Masala G; Zanna I; Ottini L; Silvestri V; Hollestelle A; Hooning MJ; Novaković S; Krajc M; Gago-Dominguez M; Castelao JE; Olsson H; Hedenfalk I; Saloustros E; Georgoulias V; Easton DF; Pharoah P; Dunning AM; Bishop DT; Neuhausen SL; Steele L; Ashworth A; Garcia Closas M; Houlston R; Swerdlow A; Orr N
    J Natl Cancer Inst; 2021 Apr; 113(4):453-461. PubMed ID: 32785646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
    Wang B; Wang H; Zhao A; Zhang M; Yang J
    BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male breast cancer is not congruent with the female disease.
    Fentiman IS
    Crit Rev Oncol Hematol; 2016 May; 101():119-24. PubMed ID: 26989051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy.
    Silvestri V; Rizzolo P; Scarnò M; Chillemi G; Navazio AS; Valentini V; Zelli V; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Pensotti V; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D; Ottini L
    Eur J Cancer; 2015 Nov; 51(16):2289-95. PubMed ID: 26248686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy.
    Ottini L; Rizzolo P; Zanna I; Silvestri V; Saieva C; Falchetti M; Masala G; Navazio AS; Capalbo C; Bianchi S; Manoukian S; Barile M; Peterlongo P; Caligo MA; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Cini G; Montagna M; Radice P; Palli D
    Breast Cancer Res Treat; 2014 Dec; 148(3):623-8. PubMed ID: 25385181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.
    Fletcher O; Johnson N; Orr N; Hosking FJ; Gibson LJ; Walker K; Zelenika D; Gut I; Heath S; Palles C; Coupland B; Broderick P; Schoemaker M; Jones M; Williamson J; Chilcott-Burns S; Tomczyk K; Simpson G; Jacobs KB; Chanock SJ; Hunter DJ; Tomlinson IP; Swerdlow A; Ashworth A; Ross G; dos Santos Silva I; Lathrop M; Houlston RS; Peto J
    J Natl Cancer Inst; 2011 Mar; 103(5):425-35. PubMed ID: 21263130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
    Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
    Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
    Fields EC; DeWitt P; Fisher CM; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
    Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
    PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers.
    Zheng Y; Ogundiran TO; Falusi AG; Nathanson KL; John EM; Hennis AJ; Ambs S; Domchek SM; Rebbeck TR; Simon MS; Nemesure B; Wu SY; Leske MC; Odetunde A; Niu Q; Zhang J; Afolabi C; Gamazon ER; Cox NJ; Olopade CO; Olopade OI; Huo D
    Carcinogenesis; 2013 Jul; 34(7):1520-8. PubMed ID: 23475944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic susceptibility loci for subtypes of breast cancer in an African American population.
    Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.
    Johansson I; Lauss M; Holm K; Staaf J; Nilsson C; Fjällskog ML; Ringnér M; Hedenfalk I
    Mol Oncol; 2015 Oct; 9(8):1565-79. PubMed ID: 25990542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
    Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
    Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.
    Purrington KS; Slager S; Eccles D; Yannoukakos D; Fasching PA; Miron P; Carpenter J; Chang-Claude J; Martin NG; Montgomery GW; Kristensen V; Anton-Culver H; Goodfellow P; Tapper WJ; Rafiq S; Gerty SM; Durcan L; Konstantopoulou I; Fostira F; Vratimos A; Apostolou P; Konstanta I; Kotoula V; Lakis S; Dimopoulos MA; Skarlos D; Pectasides D; Fountzilas G; Beckmann MW; Hein A; Ruebner M; Ekici AB; Hartmann A; Schulz-Wendtland R; Renner SP; Janni W; Rack B; Scholz C; Neugebauer J; Andergassen U; Lux MP; Haeberle L; Clarke C; Pathmanathan N; Rudolph A; Flesch-Janys D; Nickels S; Olson JE; Ingle JN; Olswold C; Slettedahl S; Eckel-Passow JE; Anderson SK; Visscher DW; Cafourek VL; Sicotte H; Prodduturi N; Weiderpass E; Bernstein L; Ziogas A; Ivanovich J; Giles GG; Baglietto L; Southey M; Kosma VM; Fischer HP; ; Reed MW; Cross SS; Deming-Halverson S; Shrubsole M; Cai Q; Shu XO; Daly M; Weaver J; Ross E; Klemp J; Sharma P; Torres D; Rüdiger T; Wölfing H; Ulmer HU; Försti A; Khoury T; Kumar S; Pilarski R; Shapiro CL; Greco D; Heikkilä P; Aittomäki K; Blomqvist C; Irwanto A; Liu J; Pankratz VS; Wang X; Severi G; Mannermaa A; Easton D; Hall P; Brauch H; Cox A; Zheng W; Godwin AK; Hamann U; Ambrosone C; Toland AE; Nevanlinna H; Vachon CM; Couch FJ
    Carcinogenesis; 2014 May; 35(5):1012-9. PubMed ID: 24325915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male breast cancer in the veterans affairs population: a comparative analysis.
    Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
    Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy.
    Ottini L; Silvestri V; Saieva C; Rizzolo P; Zanna I; Falchetti M; Masala G; Navazio AS; Graziano V; Bianchi S; Manoukian S; Barile M; Peterlongo P; D'Amico C; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D
    Breast Cancer Res Treat; 2013 Apr; 138(3):861-8. PubMed ID: 23468243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer.
    Yao N; Shi W; Liu T; Siyin ST; Wang W; Duan N; Xu G; Qu J
    Sci Rep; 2022 Jan; 12(1):220. PubMed ID: 34997151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic characteristics and survival of male breast cancer.
    Liu D; Xie G; Chen M
    Int J Clin Oncol; 2014 Apr; 19(2):280-7. PubMed ID: 23640121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone receptor-positive breast cancer and black race: does sex matter?
    Eskander MF; Li Y; Bhattacharyya O; Tsung A; Oppong BA; Hamad A; Gatti-Mays M; Obeng-Gyasi S
    Breast Cancer Res Treat; 2021 Nov; 190(1):111-119. PubMed ID: 34383180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
    Reeves GK; Travis RC; Green J; Bull D; Tipper S; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
    JAMA; 2010 Jul; 304(4):426-34. PubMed ID: 20664043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.